Literature DB >> 6182798

Experimental intraocular proliferation and neovascularization.

A Ophir, M S Blumenkranz, A J Claflin.   

Abstract

An experimental model of massive periretinal proliferation and intraocular neovascularization, produced in rabbits by the intravitreal injection of 250,00 cultured heterologous fibroblasts, showed no significant difference in the detachment rate (69% to 100%) or neovascularization rate (45% to 88%) between the animals injected with autologous cells and those injected with heterologous cells. Dermal fibroblasts produced a slightly higher detachment rate than conjunctival fibroblasts and were equally effective after reconstitution and subculture from liquid nitrogen storage in 7% dimethyl sulfoxide. Heterologous cells produced no clinical or histologic evidence of rejection when compared with autologous cells in the same animal and had the following advantages: (1) elimination of several biopsies and extended cell culture time; (2) a ready source of cryopreserved cells is available; (3) multiple injections of many animals can be performed within a short time; (4) in vivo and in vitro drug testing can be correlated on the same cell line.

Entities:  

Mesh:

Year:  1982        PMID: 6182798     DOI: 10.1016/0002-9394(82)90238-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Pharmacological therapy for proliferative vitreoretinopathy.

Authors:  N D Radtke; A D Weinsieder; R J Ballou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

2.  Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.

Authors:  Hetian Lei; Marc-André Rhéaume; Gisela Velez; Shizuo Mukai; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-24       Impact factor: 4.799

3.  The effects of injections of cultured fibroblasts into the rabbit vitreous.

Authors:  C A Hitchins; I Grierson; P S Hiscott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

Review 4.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

5.  Temporary use of silicone oil in the treatment of proliferative vitreoretinopathy. An experimental study with a new animal model.

Authors:  M Gonvers; R Thresher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

6.  Experimental traction retinal detachment in the cat.

Authors:  C A Wilson; J A Khawly; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization.

Authors:  A N Antoszyk; J L Gottlieb; R Machemer; D L Hatchell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993       Impact factor: 3.117

8.  Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR.

Authors:  M Salah-Eldin; G A Peyman; M el-Aswad; B Bandok; M M Bahgat; M R Niesman
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.